SCS Sponsor III LLC
CIK: 0001850379
Associated companies
Transaction History
| PROK | ▲ Buy | Option Exercise | 6,220,000 | $0 | 7/11/2022 | View on chart |
| PROK | ▼ Sell | Other | 6,860,000 | $0 | 7/11/2022 | View on chart |
| PROK | ▲ Buy | Option Exercise | 6,220,000 | $0 | 7/11/2022 | View on chart |
| PROK | ▼ Sell | Other | 6,860,000 | $0 | 7/11/2022 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 3, 2026
PROK: Eight ProKidney Abstracts Chosen for Kidney Week 2026
ProKidney Corp. announced that eight of its research abstracts were chosen to be presented at the American Society of Nephrology’s Kidney Week 2026. The selection highlights the company’s active research program in kidney disease. It shows that ProKidney’s work is gaining recognition from the nephrology community. The news may support the company’s long‑term development plans.
PROK: Eight ProKidney Abstracts Chosen for Kidney Week 2026. ProKidney Corp. announced that eight of its research abstracts were chosen to be presented at the American Society of Nephrology’s Kidney Week 2026. The selection highlights the company’s active research program in kidney disease. It shows that ProKidney’s work is gaining recognition from the nephrology community. The news may support the company’s long‑term development plans.